Press Release BofA Securities Asia Forum Gathers Global Investors Amid Surge in Hedge Funds Allocations Key points BofA Securities hosted its fourth annual Asia Alternatives Forum, bringing… CISION PRNewswireJune 1, 2026
Traveloka 6.6 Mid Year Sale: Up to S$66 Off Flights, Hotels and Attractions for Singapore Travelers Traveloka’s 6.6 Mid Year Sale Unlocks $66 Sitewide Discounts and 1-for-1 Attraction… CISION PRNewswireJune 1, 2026
Deloitte appoints Robert Hillard as Asia Pacific Chief Executive Officer HONG KONG, June 1, 2026 /PRNewswire/ — Deloitte Asia Pacific today announced… CISION PRNewswireJune 1, 2026
ASCO 2026 | CStone Presents Updated Clinical Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody), Reinforcing Triple-Target Synergy and Delivering Strong Proof-of-Concept First-line NSCLC – Compelling Activity Across All PD-L1 SubgroupsIn first-line non-small cell… CISION PRNewswireJune 1, 2026
Long-term Follow-up Results of CARsgen's Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 ASCO Annual Meeting SHANGHAI, June 1, 2026 /PRNewswire/ — CARsgen Therapeutics Holdings Limited (Stock Code:… CISION PRNewswireJune 1, 2026
Business Press Release MICROIP to Debut "AI Vehicle System Business Group" and Edge AI Innovations at COMPUTEX 2026 TAIPEI, June 1, 2026 /PRNewswire/ — MICROIP (TPEx: 7796), specializing in AI… CISION PRNewswireJune 1, 2026
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview TAIPEI, June 1, 2026 /PRNewswire/ — Jyong Biotech Ltd. (Nasdaq: MENS) (the… CISION PRNewswireJune 1, 2026
D3 Bio Presents First-Line Data for Elisrasib (D3S-001) at ASCO 2026; Next-Generation KRAS G12C Inhibitor Shows Landmark Efficacy in Untreated NSCLC Elisrasib monotherapy delivers an ORR of 78.0% and median PFS of 12.4… CISION PRNewswireJune 1, 2026
